AzTrials
AzTrials

Complete EdentulismNCT06324292

Effect Of Digital Smile Design on Quality Of Life In Complete Denture Wearers

A study testing complete denture, CG and complete denture, DG in people with Complete Edentulism, run by Ain Shams University at 2 sites in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the current study protocol is to compare the effect of two complete dentures made for completely edentulous patients; one digitally constructed using digital smile design (DSD) and another one conventionally constructed on the patient's quality of life and patient's satisfaction. Read more about this study

Who is it for?
Ages 40 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Complete Edentulism
What is being tested?
complete denture, CG and complete denture, DG
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
2 sitesEgypt
Study dates
1 Apr 2024to 15 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • completely edentulous patients
  • well formed edentulous ridge
  • healthy, pink, non edematous mucosa of even thickness

Who cannot join

  • heavy smokers
  • patients with parafunctional habits, temporomandibular joint disorders or orofacial motor disorders
  • patients with physicological or psychiatric condition

Trial locations and contacts

2 sites in 1 country.

Ahmed MA Mohamed, BSc MSc,MD contact

01111191337 ext. 020

ahmedmostafa@dent.asu.edu.eg

Egypt2 sites
  • Faculty of Dentistry Ain Shams University

    Cairo, 11361

  • Faculty of Dentistry, Ain Shams University

    Cairo, 11361

    ahmed MA mohamed, Bsc, Msc,MD, 01111191337 ext. 020, ahmedmostafa@dent.asu.edu.eg

Other trials in Egypt

About this study

Official title: Effect Of Digital Smile Design on Quality Of Life In Complete Denture Wearers: Randomized Clinical Trial

The aim of the current study protocol is to compare the effect of two complete dentures made for completely edentulous patients; one digitally constructed using digital smile design (DSD) and another one conventionally constructed on the patient's quality of life and patient's satisfaction.

It is a clinical trial in which two dentures will be made for each patient, one will be digitally constructed using digital smile design (DSD) and the other one using the conventional method with a washout period of 3 weeks. Each patient will receive a questionnaire "Oral Health Impact Profile -19" (OHIP -19) for the edentulous patients to evaluate his satisfaction with the denture.

Read the detailed description

Although the aesthetic results of digitally constructed dentures might be satisfactory for the patients, there is still little clinical evidence for the effect of using digital smile design DSD in denture construction on the patient's satisfaction. So, the objective of the current study is to find the effect of digital smile design (DSD) on quality of life in complete denture wearers compared to the conventionally created one. The current study is planned to be a crossover randomized Controlled Trial (RCT). The principal investigator, participants and the statistician will be blinded. Simple randomization of the patients in the will take place using a computer generated list (Software informer, Informer Technologies Inc) and allocated into two groups; a conventional denture followed by a digital group (CG) and a digital denture followed by a conventional one group (DG). Parallel allocation in ratio 1:1 will take place. The names of the participants in both groups will be placed in closed opaque sealed envelopes according to the computer generated list of random numbers and an envelope will be allocated to each patient. For blinding and allocation concealment, a third party rather than the authors and participants will be the only one to know the key so that the authors and the participants won't know in which group the participant will be. Afterwards, the authors will be informed by the randomization to be tabulated.

Being tested
complete denture, CG, complete denture, DG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • complete denture, CGProcedure or surgery

    fabrication of conventional complete denture followed by a digital denture

  • complete denture, DGProcedure or surgery

    fabrication of digital complete denture followed by a conventional one

Study groups in NCT06324292
Study groupRoleWhat they receive
conventional denture followed by a digital oneActive comparatorthe participants will receive a conventional complete denture followed by a digital one having digital smile design
Receives: Procedure: complete denture, CG
Digital denture followed by a conventional oneActive comparatorthe participants will receive a digital complete denture having digital smile design followed by a conventional one
Receives: Procedure: complete denture, DG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. quality of life assessment

    OHIP-19 questionnaires for the edentulous patient will be used. A likert scale from 0 to 5 will be employed which zero will denote the ' very bad" experience with the denture and 5 will denote the "excellent" experience

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2024
  2. Study start1 Apr 2024 (estimated)
  3. Primary completion1 Sep 2024 (estimated)
  4. Study completion15 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
The participants allocated into two groups; a conventional denture followed by a digital group (CG) and a digital denture followed by a conventional one group (DG).
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06324292
Sponsor's protocol ID
FDASU-RecID112324
Status last verified
Mar 2024
First submitted
15 Mar 2024
Last updated
26 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study protocol and statistical analysis plan will be available matching the criteria of the journal. However, data will be available from the corresponding author upon request once the paper is published.

Questions about this trial

What is this clinical trial studying?

A study testing complete denture, CG and complete denture, DG in people with Complete Edentulism, run by Ain Shams University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed MA Mohamed, BSc MSc,MD (01111191337 ext. 020, ahmedmostafa@dent.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

quality of life assessment (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in